AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,607 | -20.6% | 671 | -9.2% | 0.00% | -100.0% |
Q2 2023 | $20,928 | +18.8% | 739 | -3.7% | 0.00% | – |
Q1 2023 | $17,618 | -36.0% | 767 | -21.8% | 0.00% | -100.0% |
Q4 2022 | $27,546 | -1.6% | 981 | -2.2% | 0.00% | 0.0% |
Q3 2022 | $28,000 | +133.3% | 1,003 | +92.5% | 0.00% | – |
Q2 2022 | $12,000 | +300.0% | 521 | +337.8% | 0.00% | – |
Q1 2022 | $3,000 | +200.0% | 119 | +164.4% | 0.00% | – |
Q4 2021 | $1,000 | -66.7% | 45 | -38.4% | 0.00% | – |
Q3 2021 | $3,000 | -70.0% | 73 | -59.0% | 0.00% | – |
Q2 2021 | $10,000 | +66.7% | 178 | +61.8% | 0.00% | – |
Q1 2021 | $6,000 | +100.0% | 110 | +50.7% | 0.00% | – |
Q4 2020 | $3,000 | 0.0% | 73 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | +50.0% | 73 | +92.1% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 38 | +5.6% | 0.00% | – |
Q1 2020 | $1,000 | -66.7% | 36 | -33.3% | 0.00% | – |
Q4 2019 | $3,000 | +200.0% | 54 | +200.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 18 | -63.3% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 49 | +75.0% | 0.00% | – |
Q1 2019 | $2,000 | – | 28 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |